Anisha Apte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anisha Apte has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Elise McKenna
Department of General and Thoracic Surgery, Children's National Medical Center, Washington, District of Columbia, United States
4 shared publicationsMarc A. Levitt
Department of Surgery, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
4 shared publications- Carlos Zgheib
Laboratory for Fetal and Regenerative Biology, Department of Surgery, College of Medicine, University of Arizona, Tucson, AZ 85721, USA
1 shared publication - David M. Jackson
Ceria Therapeutics, Inc., Tucson, AZ 85721, USA
1 shared publication - Fayez K. Ghishan
University of Arizona
1 shared publication - Giulia Brisighelli
Faculty of Health Sciences, Department of Paediatric Surgery, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa
1 shared publication
Latest Publications
- Open Access
- 9 December 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (12) , 1573
Oral Delivery of miR146a Conjugated to Cerium Oxide Nanoparticles Improves an Established T Cell-Mediated Experimental Colitis in Mice
Background: Dysregulated inflammation and oxidative stress are strongly implicated in the pathogenesis of inflammatory bowel disease. We have developed a novel therapeutic that targets inflammation and oxidative stress. It is comprised of microRNA-146a (miR146a)-loaded cerium oxide nanoparticles (CNPs) (CNP-miR146a). We hypothesized that oral delivery of CNP-miR146a would reduce colonic inflammation in a mouse model of established, chronic, T cell-mediated colitis. Methods: The stability of CNP-miR146a and mucosal delivery was assessed in vitro with simulated gastrointestinal fluid and in vivo after oral gavage by quantitative real-time RT-PCR. The efficacy of orally administered CNP-miR146a was tested in mice with established colitis using the model of adoptive naïve T-cell transfer in recombinant activating gene 2 knockout (Rag2−/−) mice. Measured outcomes included histopathology; CD45+ immune cell infiltration; oxidative DNA damage (tissue 8-hydroxy-2′-deoxyguanosine; 8-OHdG); expression of IL-6 and TNF mRNA and protein, and flow cytometry analysis of lamina propria Th1 and Th17 cell populations. Results: miR146a expression remained stable in simulated gastric and intestinal conditions. miR146a expression increased in the intestines of mice six hours following oral gavage of CNP-miR146a. Oral delivery of CNP-miR146a in mice with colitis was associated with reduced inflammation and oxidative stress in the proximal and distal colons as evidenced by histopathology scoring, reduced immune cell infiltration, reduced IL-6 and TNF expression, and decreased populations of CD4+Tbet+IFNg+ Th1, CD4+RorgT+IL17+ Th17, as well as pathogenic double positive IFNg+IL17+ T cells. Conclusions: CNP-miR146a represents a novel orally available therapeutic with high potential to advance into clinical trials.
- 9 December 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (12) , 1573
Open AccessOral Delivery of miR146a Conjugated to Cerium Oxide Nanoparticles Improves an Established T Cell-Mediated Experimental Colitis in Mice
Background: Dysregulated inflammation and oxidative stress are strongly implicated in the pathogenesis of inflammatory bowel disease. We have developed a novel therapeutic that targets inflammation and oxidative stress. It is comprised of microRNA-146a (miR146a)-loaded cerium oxide nanoparticles (CNPs) (CNP-miR146a). We hypothesized that oral delivery of CNP-miR146a would reduce colonic inflammation in a mouse model of established, chronic, T cell-mediated colitis. Methods: The stability of CNP-miR146a and mucosal delivery was assessed in vitro with simulated gastrointestinal fluid and in vivo after oral gavage by quantitative real-time RT-PCR. The efficacy of orally administered CNP-miR146a was tested in mice with established colitis using the model of adoptive naïve T-cell transfer in recombinant activating gene 2 knockout (Rag2−/−) mice. Measured outcomes included histopathology; CD45+ immune cell infiltration; oxidative DNA damage (tissue 8-hydroxy-2′-deoxyguanosine; 8-OHdG); expression of IL-6 and TNF mRNA and protein, and flow cytometry analysis of lamina propria Th1 and Th17 cell populations. Results: miR146a expression remained stable in simulated gastric and intestinal conditions. miR146a expression increased in the intestines of mice six hours following oral gavage of CNP-miR146a. Oral delivery of CNP-miR146a in mice with colitis was associated with reduced inflammation and oxidative stress in the proximal and distal colons as evidenced by histopathology scoring, reduced immune cell infiltration, reduced IL-6 and TNF expression, and decreased populations of CD4+Tbet+IFNg+ Th1, CD4+RorgT+IL17+ Th17, as well as pathogenic double positive IFNg+IL17+ T cells. Conclusions: CNP-miR146a represents a novel orally available therapeutic with high potential to advance into clinical trials.
- Open Access
- 28 January 2020
- Published by Georg Thieme Verlag KG in European Journal of Pediatric Surgery Reports
- Vol. 08 (01) , e99-e101
Image of the Month: Decision-Making in Surgery for Late Onset Hirschsprung Disease
We present a case of a 14-year-old boy with chronic distension, poor growth, and chronic constipation. He undergoes anorectal manometry and rectal biopsy, confirming the diagnosis of Hirschsprung disease (HD). The case is presented with a key image and associated questions to prompt discussion on strategies for management and treatment of HD in late-diagnosed children.
- 28 January 2020
- Published by Georg Thieme Verlag KG in European Journal of Pediatric Surgery Reports
- Vol. 08 (01) , e99-e101
Open AccessImage of the Month: Decision-Making in Surgery for Late Onset Hirschsprung Disease
We present a case of a 14-year-old boy with chronic distension, poor growth, and chronic constipation. He undergoes anorectal manometry and rectal biopsy, confirming the diagnosis of Hirschsprung disease (HD). The case is presented with a key image and associated questions to prompt discussion on strategies for management and treatment of HD in late-diagnosed children.
- Open Access
- 28 January 2020
- Published by Georg Thieme Verlag KG in European Journal of Pediatric Surgery Reports
- Vol. 08 (01) , e108-e111
Image of the Month: High Pressure Distal Colostogram in a Patient with an Anorectal Malformation
An adequately performed high pressure distal colostogram is crucial to plan surgery in male patients born with anorectal malformations. We present two male patients that underwent a divided sigmoid colostomy with distal mucus fistula in the neonatal period and at 6 months of age underwent a high pressure distal colostogram. In the discussion, we will give some tricks beyond the known rules: how to correctly interpret a high pressure distal colostogram, how to identify the level of a recto-urinary fistula, and how to accurately plan the surgical approach.
- 28 January 2020
- Published by Georg Thieme Verlag KG in European Journal of Pediatric Surgery Reports
- Vol. 08 (01) , e108-e111
Open AccessImage of the Month: High Pressure Distal Colostogram in a Patient with an Anorectal Malformation
An adequately performed high pressure distal colostogram is crucial to plan surgery in male patients born with anorectal malformations. We present two male patients that underwent a divided sigmoid colostomy with distal mucus fistula in the neonatal period and at 6 months of age underwent a high pressure distal colostogram. In the discussion, we will give some tricks beyond the known rules: how to correctly interpret a high pressure distal colostogram, how to identify the level of a recto-urinary fistula, and how to accurately plan the surgical approach.
- Open Access
- 9 January 2020
- Published by Georg Thieme Verlag KG in European Journal of Pediatric Surgery Reports
- Vol. 08 (01) , e102-e104
Image of the Month: Enterocolitis Following a Pull-through for Total Colonic Hirschsprung Disease in a 2-Year-Old Boy
We present a case of a 2-year-old boy with total colonic Hirschsprung disease (HD) who underwent an ileostomy as a newborn, and then colectomy and pull-through at 10 months of age. Since then he has presented four times with enterocolitis. The case is presented with a focus on evaluating patients with HD who present with obstructive symptoms following corrective surgery. A key image is presented along with questions formatted as a quiz to guide readers through critically evaluating the case. Received: 29 May 2020 Accepted: 18 August 2020 Publication Date: 09 January 2021 (online) © 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 9 January 2020
- Published by Georg Thieme Verlag KG in European Journal of Pediatric Surgery Reports
- Vol. 08 (01) , e102-e104
Open AccessImage of the Month: Enterocolitis Following a Pull-through for Total Colonic Hirschsprung Disease in a 2-Year-Old Boy
We present a case of a 2-year-old boy with total colonic Hirschsprung disease (HD) who underwent an ileostomy as a newborn, and then colectomy and pull-through at 10 months of age. Since then he has presented four times with enterocolitis. The case is presented with a focus on evaluating patients with HD who present with obstructive symptoms following corrective surgery. A key image is presented along with questions formatted as a quiz to guide readers through critically evaluating the case. Received: 29 May 2020 Accepted: 18 August 2020 Publication Date: 09 January 2021 (online) © 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 1 January 2020
- Published by Georg Thieme Verlag KG in European Journal of Pediatric Surgery Reports
- Vol. 8 (1) , E105-E107
Image of the Month: How to Select the Ideal Surgical Approach in Male Anorectal Malformation with No Visible Fistula
We present a case of a 6-month-old male infant with an anorectal malformation (ARM) who underwent colostomy as a newborn, and now presents for definitive repair. A colostogram is shown to identify the malformation and to help plan for the ideal surgical approach. The case is presented with a focus on surgical strategies for management of ARM in the male infant, with questions for the readers posed in a quiz format.
- 1 January 2020
- Published by Georg Thieme Verlag KG in European Journal of Pediatric Surgery Reports
- Vol. 8 (1) , E105-E107
Open AccessImage of the Month: How to Select the Ideal Surgical Approach in Male Anorectal Malformation with No Visible Fistula
We present a case of a 6-month-old male infant with an anorectal malformation (ARM) who underwent colostomy as a newborn, and now presents for definitive repair. A colostogram is shown to identify the malformation and to help plan for the ideal surgical approach. The case is presented with a focus on surgical strategies for management of ARM in the male infant, with questions for the readers posed in a quiz format.